JPM Healthcare Conference - Biotech in 2023?

I think what's interesting and maybe not in a great way is that, you know, it's not particularly like in the last half of the year. We have had some pretty good news come through biotech. But if you sort of look at, a look across the sector has that brought more investors into biotech? It really hasn't done that yet. And so maybe early in the year, particularly if we have like more good news, then we will see a broad, a more broad-based investor coming into biotech. That's something that I think bears watching.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.